Teva Biotech GmbH
FDA inspection history in Ulm, Germany, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Ulm, Germany.
Cited most
Across all Teva Biotech observations on file
- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.160General requirements1
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.58Maintenance1
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete Teva Biotech file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Ulm, Germany
One Form 483 · 2025 · 7 observations
Latest: Form 483, Mar 21, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-03-21 | 483 Form 483 | Ulm, Germany | 7 | $99 |
Investigators on these documents
FEI number 3007817154 · most recent document Mar 21, 2025
About Teva Biotech GmbH
How many FDA Form 483s has Teva Biotech GmbH received?
FDA Intel has 1 Form 483 on file for Teva Biotech GmbH; the most recent is dated Mar 21, 2025.
When was Teva Biotech GmbH last inspected by FDA?
The most recent FDA inspection document on file for Teva Biotech GmbH is a Form 483 dated Mar 21, 2025, for the site in Ulm, Germany.
What did FDA cite at Teva Biotech GmbH?
The regulations cited most in the observations on file for Teva Biotech GmbH are 21 CFR 211.100 (Written procedures; deviations), 2 times; 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.42 (Design and construction features), 1 time.